Jean-Michel Gonzalez, Ivann Bouteiller, Diane Lorenzo, Mohamed Gasmi, Marc Barthet
{"title":"胆道梗阻和胃出口梗阻联合治疗:胆道支架置入术和十二指肠衍生术在再干预风险方面的比较:专家单中心经验。","authors":"Jean-Michel Gonzalez, Ivann Bouteiller, Diane Lorenzo, Mohamed Gasmi, Marc Barthet","doi":"10.1080/00365521.2025.2537895","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Double malignant biliary and duodenal obstruction is a frequent and debilitating complication of advanced biliopancreatic cancers. Endoscopic ultrasound (EUS)-guided biliary and enteric drainage techniques have emerged as alternatives to ERCP and duodenal stenting (DS), but optimal therapeutic sequencing remains unclear.</p><p><strong>Patients and methods: </strong>We conducted a retrospective monocentric study including 34 patients treated for DMBO-DDO between February 2015 and December 2023. Inclusion required histologically confirmed tumors with both distal malignant biliary obstruction (DMBO) and high-grade gastric outlet obstruction (GOO). Treatment sequences were guided by the first symptom and validated by a multidisciplinary team. The primary endpoint was biliary reintervention rate according to different therapeutic combinations. Secondary endpoints included technical and clinical success, adverse events, and global reintervention rates.</p><p><strong>Results: </strong>Mean patient age was 75 years, with pancreatic adenocarcinoma being the most common (58.8%). ERCP was the first procedure in 67.6% of cases. Technical success was 100% for all biliary interventions. The overall biliary reintervention rate was 52.9%, significantly higher in ERCP-based strategies (up to 77.8%) compared to EUS-guided approaches (18.2%-40%; <i>p</i> = 0.03). Lower initial bilirubin levels (<150 μmol/L) were also associated with increased reintervention rates (77.2% vs. 23.5%; <i>p</i> = 0.019). Complication rates were low (4.4% for grade ≥ III).</p><p><strong>Conclusions: </strong>ERCP-first strategies for DMBO in the association of GOO showed significantly higher biliary reintervention rates compared to EUS-guided approaches. These findings suggest that EUS-based drainage should be favored in selected patients. Prospective multicenter studies are needed to refine treatment algorithms and confirm predictive factors for reintervention.</p>","PeriodicalId":21461,"journal":{"name":"Scandinavian Journal of Gastroenterology","volume":" ","pages":"958-965"},"PeriodicalIF":1.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combined biliary obstruction and gastric outlet obstruction management: comparison of various strategies of biliary stenting and duodenal derivation in terms of reintervention risk: an expert single-center experience.\",\"authors\":\"Jean-Michel Gonzalez, Ivann Bouteiller, Diane Lorenzo, Mohamed Gasmi, Marc Barthet\",\"doi\":\"10.1080/00365521.2025.2537895\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Double malignant biliary and duodenal obstruction is a frequent and debilitating complication of advanced biliopancreatic cancers. Endoscopic ultrasound (EUS)-guided biliary and enteric drainage techniques have emerged as alternatives to ERCP and duodenal stenting (DS), but optimal therapeutic sequencing remains unclear.</p><p><strong>Patients and methods: </strong>We conducted a retrospective monocentric study including 34 patients treated for DMBO-DDO between February 2015 and December 2023. Inclusion required histologically confirmed tumors with both distal malignant biliary obstruction (DMBO) and high-grade gastric outlet obstruction (GOO). Treatment sequences were guided by the first symptom and validated by a multidisciplinary team. The primary endpoint was biliary reintervention rate according to different therapeutic combinations. Secondary endpoints included technical and clinical success, adverse events, and global reintervention rates.</p><p><strong>Results: </strong>Mean patient age was 75 years, with pancreatic adenocarcinoma being the most common (58.8%). ERCP was the first procedure in 67.6% of cases. Technical success was 100% for all biliary interventions. The overall biliary reintervention rate was 52.9%, significantly higher in ERCP-based strategies (up to 77.8%) compared to EUS-guided approaches (18.2%-40%; <i>p</i> = 0.03). Lower initial bilirubin levels (<150 μmol/L) were also associated with increased reintervention rates (77.2% vs. 23.5%; <i>p</i> = 0.019). Complication rates were low (4.4% for grade ≥ III).</p><p><strong>Conclusions: </strong>ERCP-first strategies for DMBO in the association of GOO showed significantly higher biliary reintervention rates compared to EUS-guided approaches. These findings suggest that EUS-based drainage should be favored in selected patients. Prospective multicenter studies are needed to refine treatment algorithms and confirm predictive factors for reintervention.</p>\",\"PeriodicalId\":21461,\"journal\":{\"name\":\"Scandinavian Journal of Gastroenterology\",\"volume\":\" \",\"pages\":\"958-965\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/00365521.2025.2537895\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00365521.2025.2537895","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Combined biliary obstruction and gastric outlet obstruction management: comparison of various strategies of biliary stenting and duodenal derivation in terms of reintervention risk: an expert single-center experience.
Background: Double malignant biliary and duodenal obstruction is a frequent and debilitating complication of advanced biliopancreatic cancers. Endoscopic ultrasound (EUS)-guided biliary and enteric drainage techniques have emerged as alternatives to ERCP and duodenal stenting (DS), but optimal therapeutic sequencing remains unclear.
Patients and methods: We conducted a retrospective monocentric study including 34 patients treated for DMBO-DDO between February 2015 and December 2023. Inclusion required histologically confirmed tumors with both distal malignant biliary obstruction (DMBO) and high-grade gastric outlet obstruction (GOO). Treatment sequences were guided by the first symptom and validated by a multidisciplinary team. The primary endpoint was biliary reintervention rate according to different therapeutic combinations. Secondary endpoints included technical and clinical success, adverse events, and global reintervention rates.
Results: Mean patient age was 75 years, with pancreatic adenocarcinoma being the most common (58.8%). ERCP was the first procedure in 67.6% of cases. Technical success was 100% for all biliary interventions. The overall biliary reintervention rate was 52.9%, significantly higher in ERCP-based strategies (up to 77.8%) compared to EUS-guided approaches (18.2%-40%; p = 0.03). Lower initial bilirubin levels (<150 μmol/L) were also associated with increased reintervention rates (77.2% vs. 23.5%; p = 0.019). Complication rates were low (4.4% for grade ≥ III).
Conclusions: ERCP-first strategies for DMBO in the association of GOO showed significantly higher biliary reintervention rates compared to EUS-guided approaches. These findings suggest that EUS-based drainage should be favored in selected patients. Prospective multicenter studies are needed to refine treatment algorithms and confirm predictive factors for reintervention.
期刊介绍:
The Scandinavian Journal of Gastroenterology is one of the most important journals for international medical research in gastroenterology and hepatology with international contributors, Editorial Board, and distribution